Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Transdermal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Transdermal Drug Delivery Devices is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Transdermal Drug Delivery under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Transdermal Drug Delivery and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Transdermal Drug Delivery under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Transdermal Drug Delivery Overview
Products under Development
Transdermal Drug Delivery - Pipeline Products by Stage of Development
Table Transdermal Drug Delivery - Pipeline Products by Stage of Development
Table Transdermal Drug Delivery - Pipeline Products by Stage of Development
Transdermal Drug Delivery - Pipeline Products by Segment
Table Transdermal Drug Delivery - Pipeline Products by Segment
Table Transdermal Drug Delivery - Pipeline Products by Segment
Transdermal Drug Delivery - Pipeline Products by Territory
Table Transdermal Drug Delivery - Pipeline Products by Territory
Table Transdermal Drug Delivery - Pipeline Products by Territory
Transdermal Drug Delivery - Pipeline Products by Regulatory Path
Table Transdermal Drug Delivery - Pipeline Products by Regulatory Path
Table Transdermal Drug Delivery - Pipeline Products by Regulatory Path
Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
Table Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
Table Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
Transdermal Drug Delivery - Ongoing Clinical Trials
Table Transdermal Drug Delivery - Ongoing Clinical Trials
Table Transdermal Drug Delivery - Ongoing Clinical Trials
Transdermal Drug Delivery - Pipeline Products under Development by Companies
Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
Table Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
Transdermal Drug Delivery - Pipeline Products by Stage of Development
Table Transdermal Drug Delivery - Pipeline Products by Stage of Development
Transdermal Drug Delivery Companies and Product Overview
Table BioNxt Solutions Inc. - Ongoing Clinical Trials Overview
Table Rotigotine Transdermal Patch - A Human Clinical Pilot Study to Assess the Relative Bioavailability, Skin Adhesion and Skin Tolerance of Rotigotine Transdermal Patch
Table Brella - An Evaluation of the Safety and Effectiveness of the N-SWEAT Patch for the Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating
Carnegie Mellon University Company Overview
Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview
Table DBV Technologies SA - Ongoing Clinical Trials Overview
Table Viaskin Peanut Allergy Patch - 1-3 Years - A Double-blind, Placebo-controlled, Randomized Phase III Trial to Assess the Safety and Efficacy of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age
Table Viaskin Peanut Allergy Patch - 1-3 Years - Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut
Table Viaskin Peanut Allergy Patch - 4-11 Years - A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous Immunotherapy With DBV712 250 ìg in 4-7-year-old Children With Peanut Allergy (VITESSE)
Table Viaskin Peanut Allergy Patch - 4-11 Years - Viaskin Peanut Immunotherapy Trial to Evaluate Safety, Simplicity and Efficacy
Table SkinJect PatchIT - A Trial to Evaluate Placebo Microneedle Arrays in Healthy Human Volunteers (Part I), Followed by Proof of Concept Testing of Efficacy and Safety of Doxorubicin Microneedle Arrays in Subjects with Basal Cell Cancer (Part II)
Table Testagen HypoSpray - A Multiple-dose, Single Period, Phase II Dose Ranging Study to Examine Testagen TDS-Testosterone 5% in Adult Male Subjects
Table Testagen HypoSpray - A Single-dose, Single Period, Phase II Pharmacokinetic Study to Examine Testagen TDS-testosterone for Its Potential to be Inadvertently Transferred by Skin Contact after Dosing in Healthy Adult Subjects
Table Levellor HypoSpray Insulin - A Randomized, Multiple-dose, Single Period, Phase II/III Dose Response Study to Examine Transdermal Human Insulin in Adult Diabetic Patients
Table HD-MAP Patch - Safety, Performance, and Acceptability of Intradermal Application of an Excipient-coated High Density Micro-array Patch (HD-MAP) Delivery System: Study in Children and Their Parents/Guardians
Dec 06, 2023: LTS Receives Grant of $1.2 Million to Support the Development of Thermostable Mrna Formulations for Microneedle Array Patches
Nov 29, 2023: Aequus Reports Third Quarter 2023 Financial Highlights and General Update
Nov 16, 2023: Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles
Nov 15, 2023: Scilex Holding Company Announces Issuance of New Patent in the U.S. for Its Lead Commercial Product ZTlido (lidocaine topical system) for a Method of Relieving Pain Through the Application of a Lidocaine-Containing Patch
Nov 09, 2023: Camurus Publishes Interim Report Third Quarter 2023
Nov 09, 2023: Camurus Announces Interim Report Third Quarter 2023
Nov 09, 2023: 3M Announces Leadership Changes
Nov 07, 2023: Futura Expands Partnership with M8 Pharmaceuticals For Remainder of Central and South American Region
Nov 07, 2023: Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business
Oct 27, 2023: Nanologica Announces Interim Report Q3 2023
Oct 26, 2023: Lilly to Participate in UBS Biopharma Conference 2023
Oct 25, 2023: Eroxon Granted Marketing Authorisation in Mexico
Oct 24, 2023: 3M Reports Third Quarter 2023 Results; Company Increases Full Year Adjusted Earnings and Cash Flow Expectations
Oct 20, 2023: Lilly Confirms Date and Conference Call for Third-Quarter 2023 Financial Results Announcement
Oct 19, 2023: Futura Medical : Eroxon Launches in the United Arab Emirates
Oct 18, 2023: Vaccine Journal Highlights the Potential for Self-Administration of Vaccines Using Vaxxas High-Density Microarray Patch (HD-MAP)
Oct 04, 2023: Lilly Announces Leadership Transitions
Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
Oct 02, 2023: European Patent Office grants patent for MED3000 providing protection to 2040
Sep 28, 2023: Teva Announces Changes to Executive Management Team
Sep 27, 2023: Zylö's `Powered By Z-pod' Technology Featured in Peer-Reviewed Paper Published in Experimental Dermatology
Sep 26, 2023: Satio Receives Funding From ARPA-H to Develop SatioRx a Novel At-home, Remotely Controllable Transdermal Drug Delivery Device
Sep 20, 2023: Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
Sep 19, 2023: Revance Provides Corporate Update at Investor Day
Sep 12, 2023: Corium Announces Publication of Favorable Adlarity (Donepezil Transdermal System) Skin Irritation Clinical Trial Data
Sep 01, 2023: Kiora Pharmaceuticals Adjourns Special Meeting of Stockholders to September 27
Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
Aug 24, 2023: SK Bioscience and Vaxxas partner to develop needle-free typhoid vaccine patch
Aug 23, 2023: 3M Appoints Carrie Cox as Chairman of the Board of Directors of the Independent Health Care Company
Aug 22, 2023: Bryan Hanson Named CEO of 3M's Health Care Business Group
Aug 09, 2023: Futura Medical : MED3000 Approved for Commercialisation in Saudi Arabia Under the Brand Name Eroxon
Aug 08, 2023: Daewon Pharm Applies for Trial of Patch-Type Obesity Treatment
Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
Aug 01, 2023: Notification of Application for Manufacturing and Marketing Approval of Hp-5070 (Primary Palmar Hyperhidrosis Treatment Drug) In Japan
Jul 25, 2023: Vaxxas Opening Statement to the Standing Committee on Industry, Science and Resources
Jul 19, 2023: This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions of Women Thanks to a Partnership With Afaxys
Jul 18, 2023: Agile Therapeutics Partners with Telehealth Platforms to Expand Access to Weekly Birth Control Patch to Millions of Women
Jul 18, 2023: PharmaTher Announces Positive Research Results for PharmaPatch with N,Ndimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics
Jul 14, 2023: Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA Platform Towards FDA Submission
Jul 11, 2023: Kindeva Drug Delivery, Chiesi Group, and H&T Presspart Announce Strategic Partnership for Dose Counter Technology Production
Jul 05, 2023: Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2
Jun 28, 2023: Hkumed Invents a Novel Microneedle Array Embedded With Ultrasound-Triggered Antibacterial Nanoparticles Enabling a Breakthrough Treatment for Skin Infection
Jun 26, 2023: Agile Therapeutics Announces the Availability of Twirla to MMCAP Infuse Members
Jun 16, 2023: CS MEDICA Secures Trademark Approval in Canada
Jun 16, 2023: Lannett Successfully Emerges From Chapter 11 in Significantly Stronger Financial Position as the Company Remains on Track Toward Commercialization of Highly Promising Pipeline
Jun 12, 2023: Futura's Fast-Acting Topical Gel for the Treatment of Erectile Dysfunction Granted Marketing Authorisation by the US FDA for Over the Counter Sale
Jun 12, 2023: Agile Therapeutics Announces New Agreement with vitaCare Prescription Services to Improve Access to Twirla
Jun 05, 2023: Vaxxas Announces Interim Results from Phase I Clinical Study of First Needle-Free COVID-19 Vaccine Delivered Using Proprietary High-Density Microarray Patch (HD-MAP)
May 30, 2023: Aequus provides general update and first quarter 2023 financial highlights
May 26, 2023: CS MEDICA Onboards Distributors With First-Year Orders of Dkk 5.6m and Cash Flow Positively Effect by Shorter Lead Times
May 25, 2023: Kopran Announces Audited Financial Results for the Year Ended March 31, 2023
May 18, 2023: Salonpas Named the World's No. 1 OTC Topical Analgesic Patch Brand for the Seventh Consecutive Year
May 17, 2023: Micron Biomedical announces positive measles and rubella vaccination results from first clinical trial of microarray injection-free vaccine delivery in children
May 15, 2023: BioNxt receives approval for European clinical study of Transdermal Rotigotine Patch for Parkinson's Disease
May 15, 2023: CS MEDICA A/S's CANNASEN Pain Patch receives approval from Israel's Ministry of Health and is set to debut as the first-ever OTC product with CBD in Israel
May 15, 2023: Solasia Pharma announces consolidated financial results for the first three months of the fiscal year ending December 31, 2023
May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
May 10, 2023: Camurus: Resolutions at the annual general meeting 2023
May 09, 2023: 3M annual meeting highlights business portfolio, innovation, and actions to drive future performance
May 08, 2023: DURECT reports Q1 2023 financial results and business update
May 02, 2023: Lannett Files Prepackaged Chapter 11 Cases to Significantly Strengthen Financial Position
May 01, 2023: Aequus Provides General update and fiscal 2022 financial results
Apr 28, 2023: Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023
Apr 26, 2023: Nitto Denko announces supplementary data of consolidated financial statements for the year ended March 31, 2023
Apr 26, 2023: Nitto Denko announces summary of consolidated financial statements of fiscal 2022
Apr 25, 2023: 3M announces more layoffs
Apr 18, 2023: MED3000, Eroxon UK Launch
Apr 13, 2023: Candesant Biomedical receives FDA clearance of Brella, the first and only 3-minute SweatControl patch, to significantly reduce primary axillary hyperhidrosis (excessive underarm sweating)
Apr 13, 2023: Lilly Confirms Date and Conference Call for First-Quarter 2023 Financial Results
Apr 12, 2023: Medtronic has a layoff in California
Apr 05, 2023: SiSaf Appoints Dr. Richard Goodfellow to Board of Directors
Apr 05, 2023: Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board Update
Apr 05, 2023: Nanologica Notice Of The Annual General Meeting 2023
Apr 04, 2023: Nutriband with Kindeva Drug Delivery select Aversa Fentanyl Abuse deterrent formulation for commercial scale manufacturing process development
Apr 04, 2023: Notice of annual general meeting 2023 in Camurus AB
Apr 04, 2023: Camurus appoints Alberto Pedroncelli as Chief Medical Officer
Apr 04, 2023: Lannett Provides Financial Update
Apr 03, 2023: Revive Therapeutics advances MDMA Transdermal Patch development with purchase of MDMA Supply from PharmAla Biotech
Mar 29, 2023: Update on progress towards regulatory approval in the US
Mar 27, 2023: Notification of Approval For Manufacturing And Marketing Approval of APOHIDE Lotion 20% in Japan
Mar 18, 2023: Pivotal clinical SAHARA study shows Candesant Biomedical's investigational sweat control patch significantly reduces primary axillary hyperhidrosis (excessive underarm sweating)
Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
Mar 14, 2023: Futura confirms initial launch of MED3000 under the Eroxon brand and continued progress towards regulatory approval in US
Mar 10, 2023: GSK publishes Annual Report 2022
Mar 09, 2023: Candesant Biomedical announces late-breaking oral presentation of pivotal clinical trial data for its investigational patch to reduce excessive underarm sweating (primary axillary hyperhidrosis) at the American Academy of Dermatology 2023 Annual Meet
Mar 08, 2023: Otsuka Pharmaceutical Announces Appointments of Board Members and Statutory Auditors
Mar 01, 2023: BioNxt signs clinical study agreement and commences manufacture of clinical samples for study of transdermal Rotigotine Patch for Parkinson's Disease
Feb 15, 2023: Futura Medical to present MED3000 FM71 data at the European Society for Sexual Medicine Congress 2023
Feb 14, 2023: Solasia Pharma Announces Consolidated Financial Results for the Fiscal Year Ended December 31, 2022
Feb 13, 2023: BioNxt reports update on commercialization of Rotigotine Patch for Treatment of Parkinson's Disease
Feb 09, 2023: Vaxxas Initiates Phase I Clinical Study of First Needle-Free, Inactivated Seasonal Influenza Vaccine Quadrivalent (IIV4) Delivered Using High-Density Microarray Patch (HD-MAP)
Jan 31, 2023: Sumitomo Pharma Announces Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2023
Jan 26, 2023: Nitto Denko Announces Summary of Consolidated Financial Statements for the Third Quarter Ended December 31, 2022
Jan 25, 2023: Abion, Raphas prove strong antibody production with low-voltage microneedle patch for DNA Covid-19 vaccine
Jan 25, 2023: Lannett to Report Fiscal 2023 Second-Quarter Financial Results, Host Conference Call on Wednesday, February 1
Jan 24, 2023: 3M Reports Fourth-Quarter and Full-Year 2022 Results
Jan 24, 2023: 3M Lays off 2500 employees
Jan 19, 2023: Vaxxas Receives Australian Government Grant to Support Phase II Clinical Trials of Needle-Free COVID-19 Vaccine
Jan 19, 2023: Lilly Confirms Date and Conference Call for Fourth-Quarter 2022 Financial Results
Jan 12, 2023: Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023
Jan 12, 2023: Hisamitsu Pharmaceutical Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending February 28,2023
Jan 10, 2023: XELSTRYM (dextroamphetamine) transdermal system, CII, to be revealed as available soon at the 2023 American Professional Society of ADHD and Related Disorders (APSARD) Conference